LAS-
CL:CLINICALASCONDES
Clínica Las Condes
- Stock
Last Close
11,114.00
20/11 13:46
Market Cap
118.10B
Beta: -
Volume Today
15
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|
average inventory | 3.43B - | 1.52B 55.59% | 1.65B 8.42% | |
average payables | 22.46B - | 36.69B 63.35% | 38.01B 3.59% | |
average receivables | 126.63B - | 44.60B - | ||
book value per share | 32.00K - | 32.33K 1.02% | 23.80K 26.38% | |
capex per share | 919.47 - | 1.43K 55.92% | 498.83 65.21% | |
capex to depreciation | 0.62 - | 0.90 44.56% | 0.67 24.75% | |
capex to operating cash flow | 0.20 - | 0.24 19.13% | 0.41 68.82% | |
capex to revenue | 0.03 - | 0.05 66.04% | 0.03 40.08% | |
cash per share | 4.96K - | 4.11K 17.17% | 1.57K 61.64% | |
days of inventory on hand | 4.33 - | 1.31 69.70% | 6.79 418.21% | |
days payables outstanding | 51.65 - | 95.33 84.58% | 74.98 21.34% | |
days sales outstanding | 189.38 - | 160.96 - | ||
debt to assets | 0.35 - | 0.33 5.56% | 0.34 3.23% | |
debt to equity | 0.77 - | 0.71 7.88% | 0.72 0.80% | |
dividend yield | 0.05 - | 0.01 85.64% | ||
earnings yield | 0.12 - | 0.04 68.64% | -0.02 154.94% | |
enterprise value | 330.82B - | 288.27B 12.86% | 355.77B 23.42% | |
enterprise value over ebitda | 10.49 - | 33.96 223.83% | 246.90 627.05% | |
ev to operating cash flow | 8.80 - | 5.86 33.42% | 26.18 346.94% | |
ev to sales | 1.19 - | 1.11 7.21% | 1.76 58.64% | |
free cash flow per share | 3.57K - | 4.44K 24.43% | 712.10 83.97% | |
free cash flow yield | 0.20 - | 0.35 77.59% | 0.05 85.96% | |
graham net net | -20.80K - | -33.26K 59.89% | -18.67K 43.86% | |
graham number | 39.79K - | 18.75K 52.89% | 12.74K 32.05% | |
income quality | 2.04 - | 12.16 495.65% | -4.00 132.86% | |
intangibles to total assets | 0.02 - | 0.02 0.29% | 0.01 26.26% | |
interest coverage | 3.84 - | 0.64 83.26% | 0.72 12.88% | |
interest debt per share | 25.63K - | 24.10K 5.96% | 18.01K 25.30% | |
inventory turnover | 84.37 - | 278.43 229.99% | 53.73 80.70% | |
invested capital | 483.34B - | 458.63B 5.11% | 442.79B 3.45% | |
market cap | 151.90B - | 106.43B 29.93% | 162.81B 52.97% | |
net current asset value | -136.44B - | -136.14B 0.22% | -145.21B 6.66% | |
net debt to ebitda | 5.67 - | 21.42 277.69% | 133.91 525.13% | |
net income per share | 2.20K - | 483.14 78.03% | -303.06 162.73% | |
operating cash flow per share | 4.49K - | 5.88K 30.88% | 1.21K 79.39% | |
payables turnover | 7.07 - | 3.83 45.82% | 4.87 27.13% | |
receivables turnover | 1.93 - | 2.27 - | ||
research and ddevelopement to revenue | ||||
return on tangible assets | 0.03 - | 0.01 77.70% | -0.01 186.88% | |
revenue per share | 33.05K - | 31.04K 6.09% | 18.02K 41.94% | |
roe | 0.07 - | 0.01 78.25% | -0.01 185.21% | |
roic | 0.05 - | -0.02 129.89% | 0.00 129.07% | |
sales general and administrative to revenue | 0.05 - | 0.10 92.68% | 0.09 13.39% | |
shareholders equity per share | 32.00K - | 32.33K 1.02% | 23.80K 26.38% | |
stock based compensation to revenue | ||||
tangible asset value | 258.12B - | 260.97B 1.10% | 260.11B 0.33% | |
tangible book value per share | 30.82K - | 31.16K 1.10% | 23.18K 25.61% | |
working capital | 95.31B - | 69.37B 27.22% | 58.31B 15.95% |
All numbers in CLP (except ratios and percentages)